Emergent BioSolutions Inc. provided revenue guidance for the second quarter of 2024. For the quarter, the company reported total revenue of $160 million to $210 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.55 USD | +5.31% | +27.59% | +131.25% |
05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
05-02 | Sector Update: Health Care | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+131.25% | 291M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- EBS Stock
- News Emergent BioSolutions Inc.
- Emergent BioSolutions Inc. Provides Revenue Guidance for the Second Quarter of 2024